CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Memphis Pharmaceuticals&Chem Inds SAE is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Memphis Pharmaceuticals&Chem Inds SAE
8 El Sawah, 11725, El Amiriya
P.O.Box
Phone: +20 222843529p:+20 222843529 CAIRO, Egypt Ticker: MPCIMPCI
Business Summary
Memphis Pharmaceuticals and Chemical Industries SAE (MPCI), a member of Holding Company for Pharmaceuticals (Holdipharma), is an Egypt-based public shareholding company engaged in the research and development, manufacture, trade, marketing and distribution of pharmaceutical products for human and veterinary use. The Company produces a range of products, including Effervescent, Syrups, Creams, Tablets, Capsules, Injections and Suppositories. The Company is characterized by its production of ampoules, extracts and active principles from medicinal plants. The Company exports its products to Asian and European countries, the United States and Canada.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Head of Financial Sector Ashraf I.Tantawi
Head of Financial Mohammed M.Ali 1/1/2011
Head of Administrative and Human Resources MagdyEl Husseiny
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Memphis Pharmaceutical & Chemicals
MPCI

General Information
Number of Employees: 1,367 (As of 6/30/2012)
Outstanding Shares: 22,750,000 (As of 8/5/2024)
Stock Exchange: CAI
Fax Number: +20 222843523


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024